The insurability of innovative pharmaceutical cancer technologies
Abstract The scientific literature, including several papers published in the IJHPR, has raised the issue of the spiraling cost of cancer treatment, including that of cancer drugs and other technologies such as gene and cell therapies. In this perspective, we review three criteria for insurability a...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-12-01
|
| Series: | Israel Journal of Health Policy Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13584-020-00426-w |